Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | cGMP-PKG signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine Adenosine 💬cGMP-PKG signaling pathway
| Adenosine | 013 [3] 13, 58, 65 💬1. cGMP-PKG signaling pathway
|
||||||||||||||||
2 | cGMP-PKG signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine phosphate Adenosine phosphate 💬cGMP-PKG signaling pathway
| Adenosine phosphate | 046 [1] 46 💬2. cGMP-PKG signaling pathway
|
||||||||||||||||
3 | cGMP-PKG signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Piclidenoson Piclidenoson 💬cGMP-PKG signaling pathway
| Piclidenoson | 046 [1] 46 💬3. cGMP-PKG signaling pathway
|
||||||||||||||||
4 | Neuroactive ligand signaling 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine Adenosine 💬Neuroactive ligand signaling
| Adenosine | 013 [3] 13, 58, 65 💬4. Neuroactive ligand signaling
|
||||||||||||||||
5 | Neuroactive ligand signaling 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine phosphate Adenosine phosphate 💬Neuroactive ligand signaling
| Adenosine phosphate | 046 [1] 46 💬5. Neuroactive ligand signaling
|
||||||||||||||||
6 | Neuroactive ligand signaling 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Piclidenoson Piclidenoson 💬Neuroactive ligand signaling
| Piclidenoson | 046 [1] 46 💬6. Neuroactive ligand signaling
|
||||||||||||||||
7 | Neuroactive ligand-receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine Adenosine 💬Neuroactive ligand-receptor interaction
| Adenosine | 013 [3] 13, 58, 65 💬7. Neuroactive ligand-receptor interaction
|
||||||||||||||||
8 | Neuroactive ligand-receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine phosphate Adenosine phosphate 💬Neuroactive ligand-receptor interaction
| Adenosine phosphate | 046 [1] 46 💬8. Neuroactive ligand-receptor interaction
|
||||||||||||||||
9 | Neuroactive ligand-receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Piclidenoson Piclidenoson 💬Neuroactive ligand-receptor interaction
| Piclidenoson | 046 [1] 46 💬9. Neuroactive ligand-receptor interaction
|
||||||||||||||||
10 | Sphingolipid signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine Adenosine 💬Sphingolipid signaling pathway
| Adenosine | 013 [3] 13, 58, 65 💬10. Sphingolipid signaling pathway
|
||||||||||||||||
11 | Sphingolipid signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Adenosine phosphate Adenosine phosphate 💬Sphingolipid signaling pathway
| Adenosine phosphate | 046 [1] 46 💬11. Sphingolipid signaling pathway
|
||||||||||||||||
12 | Sphingolipid signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 4 diseases |
ADORA3 [1] ADORA3 💬cGMP-PKG signaling pathway
|
Piclidenoson Piclidenoson 💬Sphingolipid signaling pathway
| Piclidenoson | 046 [1] 46 💬12. Sphingolipid signaling pathway
|
cGMP-PKG signaling pathway
1 gene, 3 drugs (DrugBank) and 4 diseases
Neuroactive ligand signaling
1 gene, 3 drugs (DrugBank) and 4 diseases
Neuroactive ligand-receptor interaction
1 gene, 3 drugs (DrugBank) and 4 diseases
Sphingolipid signaling pathway
1 gene, 3 drugs (DrugBank) and 4 diseases